Results 61 to 70 of about 22,370 (168)

Corrigendum: Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes

Frontiers in Endocrinology, 2019
Carolyn F. Deacon
doaj   +1 more source

β Cell Gαs signaling is critical for physiological and pharmacological enhancement of insulin secretion

The Journal of Clinical Investigation
The incretin peptides glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors coordinate β cell secretion that is proportional to nutrient intake.
Megan E. Capozzi, David Bouslov, Ashot Sargsyan, Michelle Y. Chan, Alex Chen, Sarah M. Gray, Katrina Viloria, Akshay Bareja, Jonathan D. Douros, Sophie L. Lewandowski, Jason C.L. Tong, Annie Hasib, Federica Cuozzo, Elizabeth C. Ross, Matthew W. Foster, Lee S. Weinstein, Mehboob A. Hussain, Matthew J. Merrins, Francis S. Willard, Mark O. Huising, Kyle W. Sloop, David J. Hodson, David A. D’Alessio, Jonathan E. Campbell   +23 more
doaj   +1 more source

Incretin-based injectable strategies versus intensified insulin for treatment intensification and simplification in type 2 diabetes: a systematic review and meta-analysis. [PDF]

J Diabetes Metab Disord
Mahmood T, Myrtziou I, Kanakis I.
europepmc   +1 more source

Adipocytes as a Mechanistic Link Between Incretin-Based Therapies and Hair Loss. [PDF]

Biology (Basel)
Gupta AK, Kaur J, Piguet V, Mirmirani P.
europepmc   +1 more source

The Possible Hematological Cost of Metabolic Success: Do Incretin-Based Therapies Silently Trigger Anemia? [PDF]

Med Sci (Basel)
Mizdrak M, Batistić D, Mizdrak I.
europepmc   +1 more source

Foods as Modulators of GLP-1 Secretion. [PDF]

Nutrients
Tkaczenko H, Kołodziejska R, Rymuszka A, Kamiński P, Kurhaluk N.   +4 more
europepmc   +1 more source

Integrating incretin-based therapies into comprehensive obesity care: an EASO position statement. [PDF]

Lancet Reg Health Eur
Correia JC, Baker JL, Boyland E, Busetto L, Fábryová L, Helgason T, Sbraccia P, Woodward E, Yumuk V, Pataky Z, European Association for the Study of Obesity (EASO).   +10 more
europepmc   +1 more source

Fat and lean mass changes during incretin-based therapy with structured exercise and nutritional support: A retrospective real-world pilot study. [PDF]

Obes Pillars
Kucuk Yetgin M, Gletsu-Miller N, Chapman RR, Gelber E, Snyder J, Gregg D, Nabhan D.   +6 more
europepmc   +1 more source

Effects of Incretin-Based Therapies on Testosterone Levels and Incretin Response in Men with Hypogonadism: A Systematic Literature Review Following PRISMA 2020 Guidelines. [PDF]

Pharmaceuticals (Basel)
La Vignera S, Condorelli R.
europepmc   +1 more source

Beyond Weight Loss: Gut Microenvironment Modulation to Enhance Cardiometabolic Outcomes and Long-Term Adherence During Incretin-Based Therapy. [PDF]

J Clin Med
Geraci C, La Rocca F, Petrina SM, Buonauro A, Morello V, Paternò V, Santoro C, Geraci G, Esposito R.   +8 more
europepmc   +1 more source